Labcorp Holdings LH Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Biopharma Laboratory Services | $780.6M-1.6% | $793M-0.8% | $799.1M+1.8% | $784.8M+8.8% | $721.3M-6.0% | |
| Diagnostics | $2.76B+1.2% | $2.73B-1.5% | $2.77B+0.8% | $2.75B+4.5% | $2.63B+1.7% | |
| Percent of Revenue Contributed by Geography | ||||||
| Europe | 10%— | —— | 9%0.0pp | 9%0.0pp | 9%— | |
| North America | 86%— | —— | 87%0.0pp | 87%0.0pp | 87%— | |
| Other countries | 4%— | —— | 4%0.0pp | 4%0.0pp | 4%— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Labcorp Holdings break its business down?
- Labcorp Holdings (LH) reports revenue by business across 2 parts — Biopharma Laboratory Services and Diagnostics. Each is extracted from the segment footnotes and tracked over time.
- Where does Labcorp Holdings's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Labcorp Holdings's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
